multicent studi doxazosin treatment essenti hypertens franc studi efficaci toler doxazosin patient mild moder sever essenti hypertens gener practic ninety-six adult mean age year part studi placebo phase week dose-adjust phase doxazosin week mainten phase week doxazosin final mean daili dose mg signific reduct blood pressur point measur studi mean chang blood pressur end treatment mm Hg patient success failur therapeut success efficacy-evalu patient improv sever categori hypertens treatment doxazosin reduct serum cholesterol level chang statist signific calcul probabl coronari heart diseas year framingham equat chanc baselin chanc final visit twenty-six patient side effect treatment preval vertigo headach patient dose doxazosin investig assess toler excel good patient 